Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Alfresa Holdings Corporation (JP:2784)
TSE/TYO:2784
Holding JP:2784?
Track your performance easily
2784 Stock Chart & Stats
Day’s Range¥0 - ¥0
52-Week Range¥1,929.00 - ¥2,554.50
Previous Close¥2,227
Volume520.30K
Average Volume (3M)448.36K
Market Cap
¥450.67B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)13.1
Beta0.67
Next Earnings
Feb 10, 2025EPS Estimate
¥48.18Next Dividend Ex-Date
Mar 28, 2025Dividend Yield3.16%
Share Statistics
EPS (TTM)169.97
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. Volume448,362
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
¥2,181.74Price Target Upside-2.03% Downside
Rating ConsensusHold
Number of Analyst Covering1
Alfresa Holdings News
PremiumCompany Announcements
Alfresa Holdings Announces Strategic Share Buyback
PremiumCompany Announcements
Alfresa Holdings Revises Profit Forecast for 2024
PremiumCompany Announcements
Alfresa Holdings Posts Solid Q1 Gains, Optimistic FY2024 Outlook
Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
4.90% Mutual Funds
― Other Institutional Investors
90.05% Public Companies and
Individual Investors
2784 FAQ
What was Alfresa Holdings Corporation’s price range in the past 12 months?
Alfresa Holdings Corporation lowest stock price was ¥1929.00 and its highest was ¥2554.50 in the past 12 months.
What is Alfresa Holdings Corporation’s market cap?
Currently, no data Available
When is Alfresa Holdings Corporation’s upcoming earnings report date?
Alfresa Holdings Corporation’s upcoming earnings report date is Feb 10, 2025 which is in 89 days.
How were Alfresa Holdings Corporation’s earnings last quarter?
Alfresa Holdings Corporation released its earnings results on Nov 07, 2024. The company reported ¥51.55 earnings per share for the quarter, beating the consensus estimate of ¥38.151 by ¥13.399.
Is Alfresa Holdings Corporation overvalued?
According to Wall Street analysts Alfresa Holdings Corporation’s price is currently Overvalued.
Does Alfresa Holdings Corporation pay dividends?
Alfresa Holdings Corporation pays a Semiannually dividend of ¥32 which represents an annual dividend yield of 3.16%. See more information on Alfresa Holdings Corporation dividends here
What is Alfresa Holdings Corporation’s EPS estimate?
Alfresa Holdings Corporation’s EPS estimate is ¥48.18.
How many shares outstanding does Alfresa Holdings Corporation have?
Alfresa Holdings Corporation has 202,840,000 shares outstanding.
What happened to Alfresa Holdings Corporation’s price movement after its last earnings report?
Alfresa Holdings Corporation reported an EPS of ¥51.55 in its last earnings report, beating expectations of ¥38.151. Following the earnings report the stock price went up 1.567%.
Which hedge fund is a major shareholder of Alfresa Holdings Corporation?
Currently, no hedge funds are holding shares in JP:2784
---
Alfresa Holdings Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-12.62%
12-Months-Change
Fundamentals
Return on Equity
6.49%
Trailing 12-Months
Asset Growth
7.32%
Trailing 12-Months
Company Description
Alfresa Holdings Corporation
Alfresa Holdings Corp. engages in the management of its subsidiaries that deal with wholesaling, manufacturing, import, and export of pharmaceutical products, diagnostic reagents, and medical devices. It operates through the following segments: Ethical Pharmaceuticals Wholesaling, Self-Medication Products Wholesaling, Manufacturing, and Medical-related. The Ethical Pharmaceuticals Wholesaling segment provides wholesale prescription drugs, medical diagnostic reagents, medical devices, equipment, and materials to hospitals, clinics, dispensing pharmacies, and other institutions. The Self-Medication Products Wholesaling segment sells over-the-counter drugs, health food, and supplements. The Manufacturing segment manufactures and markets pharmaceutical ingredients, pharmaceuticals, diagnostic reagents, and medical devices. The Medical-related segment offers medical services through its dispensing pharmacies. The company was founded on September 29, 2003 and is headquartered in Tokyo, Japan.
---
2784 Stock 12 Month Forecast
Average Price Target
¥2,181.74
▼(-2.03% Downside)
Technical Analysis
---